Abstract
Viruses have brought humanity many challenges: respiratory infection, cancer, neurological impairment and immunosuppression to name a few. Virology research over the last 601 years has responded to reduce this disease burden with vaccines and antivirals. Despite this long history, the COVID-19 pandemic has brought unprecedented attention to the field of virology. Some of this attention is focused on concern about the safe conduct of research with human pathogens. A small but vocal group of individuals has seized upon these concerns - conflating legitimate questions about safely conducting virus-related research with uncertainties over the origins of SARS-CoV-2. The result has fueled public confusion and, in many instances, ill-informed condemnation of virology. With this article, we seek to promote a return to rational discourse. We explain the use of gain-of-function approaches in science, discuss the possible origins of SARS-CoV-2 and outline current regulatory structures that provide oversight for virological research in the United States. By offering our expertise, we - a broad group of working virologists - seek to aid policy makers in navigating these controversial issues. Balanced, evidence-based discourse is essential to addressing public concern while maintaining and expanding much-needed research in virology.
Original language | English (US) |
---|---|
Journal | mBio |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2023 |
Bibliographical note
Publisher Copyright:Copyright © 2023 Goodrum et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Keywords
- COVID-19
- Coronavirus
- DURC
- Gain of function
- SARS-CoV-2
- biosafety
- influenza
- pandemic
- vaccines
- zoonosis
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't